December 19, 2025

From Clinical Trial to Clinic: Neurostimulation Improves Outcomes in Post-Stroke Swallowing Recovery

Baptist Health Brain & Spine Care is the first in Florida to implement this type of targeted pharyngeal neurostimulation therapy for post-stroke dysphagia.

Baptist Health South Florida

December 19, 2025

OCT and Imaging in Central Nervous System Diseases

The eye as a window to the brain

The Ophthalmologist

December 16, 2025

Saturated Fat Benefits Vary by Risk

New systematic review finds cardiovascular benefits only in high-risk patients, challenges blanket dietary restrictions

Conexiant

December 12, 2025

From Recurrent Syncope to Successful Neurosurgical Intervention: A Young Mother’s Path to Seizure Freedom

When 27-year-old María Ferreira first began experiencing fainting spells and moments of disorientation, she never imagined that the cause would be a rare brain condition resulting in epileptic seizures.

Baptist Health South Florida

December 10, 2025

DOACs in PE: Need for Risk Stratification

New perspective calls for dynamic, multidimensional stratification systems to address patient heterogeneity that is overlooked by standardized protocols.

Conexiant

December 09, 2025

Rapid Stroke Intervention Leads to Full Recovery in 24 Hours

On what began as a normal morning a few months ago, Todd Meiklejohn, a 58-year-old assistant principal at Miami’s Robert Morgan Technical College, experienced a life-altering event.

Baptist Health South Florida

December 05, 2025

Dr. Italo Linfante Named 2025 Neurointerventional Pioneering Award Recipient

Renowned Miami Neuroscience Institute physician honored for leadership, innovation and groundbreaking stroke research

Baptist Health South Florida

December 04, 2025

FDA Approves Biologic for Nerve Repair

A newly licensed biologic offers a novel approach to repairing complex peripheral nerve injuries across pediatric and adult populations.

Conexiant

December 02, 2025

Fatal Neurotoxicity After Transdermal Ivermectin: What’s Your Diagnosis?

A woman in her early 40s was found unconscious after 1 month of nightly, high-dose transdermal ivermectin use for scabies, presenting with severe neurologic decline and a fatal plasma drug level—what’s your diagnosis?

Conexiant